Naturewise Biotech & Medicals (ROCO:4732) Operating Cash Flow per Share : NT$-0.05 (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Naturewise Biotech & Medicals Operating Cash Flow per Share?

Naturewise Biotech & Medicals's operating cash flow per share for the six months ended in Dec. 2024 was NT$-0.31. Naturewise Biotech & Medicals's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-0.05.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Naturewise Biotech & Medicals was -105.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Naturewise Biotech & Medicals's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Naturewise Biotech & Medicals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 26.50% per year. The lowest was -66.10% per year. And the median was -19.25% per year.

ROCO:4732's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Naturewise Biotech & Medicals Operating Cash Flow per Share Historical Data

The historical data trend for Naturewise Biotech & Medicals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturewise Biotech & Medicals Operating Cash Flow per Share Chart

Naturewise Biotech & Medicals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.99

0.60

0.25

1.23

-0.06

Naturewise Biotech & Medicals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.13	0.46	0.81	0.26	-0.31

Competitive Comparison of Naturewise Biotech & Medicals's Operating Cash Flow per Share

For the Biotechnology subindustry, Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Naturewise Biotech & Medicals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Naturewise Biotech & Medicals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Naturewise Biotech & Medicals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-2.795	/	44.850
	=	-0.06

Naturewise Biotech & Medicals's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-17.64	/	56.097
	=	-0.31

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.05

Naturewise Biotech & Medicals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Naturewise Biotech & Medicals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Naturewise Biotech & Medicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Naturewise Biotech & Medicals Corp (ROCO:4732) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 36, Bade Road, 6th Floor, Section 3, Songshan District, Taipei, TWN, 105

Website

https://www.naturewise.com.tw

Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.

Naturewise Biotech & Medicals Headlines

No Headlines